English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Research in drug release field, nowadays, focuses on more efficient systems for better release of the drug and wider timespan of action, granting several benefits to the patient’s organism and to the industry. The present work aims on developing a matrix of polymer nanocomposite based on Polyvinylpyrrolidone (PVP), bentonite clay and two different vanadium oxides, via spray drying technique. The goal is to achieve a long and steady release of metformin hydrochloride in future formulations with this drug. Since either the nanocomposites or metformin hydrochloride is highly hydrophilic, it is most suited for a future formulation of tablets. For now, the nanocomposites obtained were characterized through Nuclear Magnetic Resonance (NMR), Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD), Thermogravimetric Analysis (TGA) and Fourier Transform Infrared Spectroscopy (FTIR). The SEM and XRD analysis portrayed a very amorphous and homogenized material. TGA and FTIR proved the insertion of the nanoparticles, thus granting to the new material a slightly higher thermal resistance. The NMR analysis, using T1H parameters, is key for determining the formulations would behave better for extending the resistance of the nanocomposite’s matrix with the drug in later dissolution of tablets.

PVP/Clay/Vanadium Oxide Nanocomposites Development and Characterization for Potential Use as Controlled Drug Release Matrix in Diabetes’ Treatment